510(k) Report

510(k) · Cleared

Cleared

Topiramate Assay, Ark Topiramate Calibrator and Ark Topiramate Control, Models 5015-0001-000, 5015-0002-00, 5015-0003-00

K083799510(k) TraditionalCleared Apr 16, 2009115-day reviewClass II21 CFR 862.3350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ark Diagnostics, Inc. · NWM Immunoassay, Anti-Seizure Drug

Cleared on Apr 16, 2009 as substantially equivalent to K070645 (Seradyn, Inc., 2007) and 2 other predicates after a 115-day review. Its family tree reaches back 2 generations to 1997. 5 later devices descend from it.

Decided
Apr 16, 2009
Review
115 days
Class
Class II
Product code
NWM
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K970510 (1997). 4 ancestors in all, the oldest K970509 (1997). 5 later devices descend from it, 4 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1997: 2 other ancestors2021: 1 descendant cleared2009: 1 descendant cleared2016: 1 descendant cleared2010: 1 descendant cleared2024: 1 descendant clearedK970510 · Innoflour Topiramate Reagent Set · Oxis Intl., Inc. · 1997K070645 · Seradyn QMS Topiramate · Seradyn, Inc. · 20071995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 4 descendants2 generations forward: 1 descendant K070645 · Seradyn QMS Topiramate · Seradyn, Inc. · 2007K970510 · Innoflour Topiramate Reagent Set · Oxis Intl., Inc. · 19970
  1. Root · 2 generations backK970510 Innoflour Topiramate Reagent SetOxis Intl., Inc. · 1997
  2. 1 generation backK070645 Seradyn QMS TopiramateSeradyn, Inc. · 2007
  3. This deviceK083799 Topiramate Assay, Ark Topiramate Calibrator and Ark Topiramate…Ark Diagnostics, Inc. · 2009
  4. Descendant · cites it directly · 1 of its ownK091653 Ark Levetiracetam Assay, Ark Levetiracetam Calibrator and Ark…Ark Diagnostics, Inc. · 2009
  5. Descendant · 2 generations on · 0 of its ownK232522 ARK Levetiracetam II AssayArk Diagnostics, Inc. · 2024
  6. Descendant · cites it directly · 0 of its ownK201089 ARK Lacosamide AssayArk Diagnostics, Inc. · 2021
  7. Descendant · cites it directly · 0 of its ownK153596 ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite…Ark Diagnostics, Inc. · 2016
  8. Descendant · cites it directly · 0 of its ownK101574 Ark Gabapentin Assay, Ark Gabepentin Califrator, and Ark Gabapentin…Ark Diagnostics, Inc. · 2010

Most influential descendants

Showing 5 of 5 · See all
  • K091653Ark Levetiracetam Assay, Ark Levetiracetam Calibrator and Ark Levetiracetam Control…Ark Diagnostics, Inc. · 2009 · cites it directly1descendant
  • K232522ARK Levetiracetam II AssayArk Diagnostics, Inc. · 2024 · 2 generations on0descendants
  • K201089ARK Lacosamide AssayArk Diagnostics, Inc. · 2021 · cites it directly0descendants
  • K153596ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK…Ark Diagnostics, Inc. · 2016 · cites it directly0descendants
  • K101574Ark Gabapentin Assay, Ark Gabepentin Califrator, and Ark Gabapentin Control…Ark Diagnostics, Inc. · 2010 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K970510Innoflour Topiramate Reagent SetOxis Intl., Inc.1997—
−1K070645Seradyn QMS TopiramateSeradyn, Inc.2007—
0 (this device)K083799Topiramate Assay, Ark Topiramate Calibrator and Ark Topiramate Control, Models…Ark Diagnostics, Inc.2009—
+1K091653Ark Levetiracetam Assay, Ark Levetiracetam Calibrator and Ark Levetiracetam…Ark Diagnostics, Inc.2009—
+2K232522ARK Levetiracetam II AssayArk Diagnostics, Inc.2024—
+1K201089ARK Lacosamide AssayArk Diagnostics, Inc.2021—
+1K153596ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator…Ark Diagnostics, Inc.2016—
+1K101574Ark Gabapentin Assay, Ark Gabepentin Califrator, and Ark Gabapentin Control…Ark Diagnostics, Inc.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199720

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201010
201610
202110
202410
FIG. 1 — Lineage of K083799, 1997–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NWM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NWM device

  1. #1 K201089 ARK Lacosamide Assayscore 2.4 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070645Seradyn QMS Topiramate
Summary page 1
…CFR 862.3200 DLJ, 21 CFR 862.3280 LAS) 807.92 (a)(3): Identification of the legally marketed predicate device Seradyn QMS® Topiramate Assay K070645 Seradyn QMS® Topiramate Calibrator K970509 INNOFLUOR Seradyn QMS® Topiramate Control…
Seradyn, Inc.2007—
*K970509Innoflour Calibrator Reagent Set
Summary page 1
…ion of the legally marketed predicate device Seradyn QMS® Topiramate Assay K070645 Seradyn QMS® Topiramate Calibrator K970509 INNOFLUOR Seradyn QMS® Topiramate Control K970517 INNOFLUOR ARK Diagnostics, Inc. - 5 10(k) Summary…
Oxis Intl., Inc.1997—
*K970517Innofluor Topiramate Control Set
Summary page 1
…K070645 Seradyn QMS® Topiramate Calibrator K970509 INNOFLUOR Seradyn QMS® Topiramate Control K970517 INNOFLUOR ARK Diagnostics, Inc. - 5 10(k) Summary, Rev. 4 page 2 of 10 807.92 (a)(…
Oxis Intl., Inc.1997—

What descends from it? (5)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K091653Ark Levetiracetam Assay, Ark Levetiracetam Calibrator and Ark Levetiracetam Control…Ark Diagnostics, Inc.20091
K201089ARK Lacosamide AssayArk Diagnostics, Inc.20210
K153596ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK…Ark Diagnostics, Inc.20160
K101574Ark Gabapentin Assay, Ark Gabepentin Califrator, and Ark Gabapentin Control…Ark Diagnostics, Inc.20100

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 10.0 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K091653 (Ark Diagnostics, Inc., 2009) has gone furthest, with 1 descendant of its own.

How does its category compare?

All NWM devices

NWM Immunoassay, Anti-Seizure Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · NWM

1in 2021

2007: 12009: 22021: 1
2007high 2 (2009) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NWM

Too few NWM 510(k)s in any year since 2007 to give a median.

Recalls per year · NWM

No recall names NWM since 2007.

Adverse event reports per year · NWM

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2025

MAUDE reports naming product code NWM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20092—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

The ARKTM Topiramate Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of topiramate in human serum or plasma on automated clinical chemistry analyzers.

The results obtained are used in the diagnosis and treatment of topiramate overdose and in monitoring levels of topiramate to help ensure appropriate therapy.

The ARKTM Topiramate Calibrator is intended for use in calibration of the ARK Topiramate Assay.

The ARKTM Topiramate Control is intended for use in quality control of the ARK Topiramate Assay.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083799: Topiramate Assay, Ark Topiramate Calibrator and Ark Topiramate Control, Models 5015-0001-000, 5015-0002-00, 5015-0003-00.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083799

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026